President Donald Trump on Saturday directed his administration to speed up reviews of certain psychedelic drugs, including ibogaine, which recently has been embraced by combat veterans and ...

By Kamal Choudhury and Christy Santhosh May 18 (Reuters) - U.S. President Donald Trump's executive order to accelerate ...

April 20 (Reuters) - Shares of psychedelic drug developers rose on Monday after U.S. President Donald Trump signed an executive order directing health regulators to speed up reviews ‌of psychedelic ...

The Food and Drug Administration has announced efforts to expedite its research into perception-altering psychedelic ...

The US president said his directive will help "dramatically accelerate" access to research and treatments on psychedelic ...

Executive order to speed access to psychedelic treatments likely to have limited legal impact despite high-profile push ...

The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic drugs being developed to treat mental health conditions, including depression, the latest step by the ...

The order instructs the FDA to expedite review of drugs such as ibogaine, a drug that veterans' groups have said can help treat post-traumatic stress disorder.